Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

PFE

Pfizer Inc

Jan 16 • 04:00PM ET

25.65

-0.24 -0.93 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Today, 6:00 AMPfizer shares fall after the company agrees to exit its 11.7% stake in ViiV Healthcare in a deal that will net it $1.875 billion, with closing expected in Q1 2026.

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Scroll to Statements

Index	S&P 500	P/E	14.95	EPS (ttm)	1.72	Insider Own	0.09%	Shs Outstand	5.69B	Perf Week	0.67%
Market Cap	145.84B	Forward P/E	8.59	EPS next Y	2.99	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	0.47%
Enterprise Value	192.86B	PEG	-	EPS next Q	0.58	Inst Own	66.74%	Short Float	2.29%	Perf Quarter	5.86%
Income	9.80B	P/S	2.32	EPS this Y	0.49%	Inst Trans	-0.50%	Short Ratio	2.05	Perf Half Y	4.82%
Sales	62.78B	P/B	1.57	EPS next Y	-4.43%	ROA	4.58%	Short Interest	130.02M	Perf YTD	3.01%
Book/sh	16.32	P/C	9.73	EPS next 5Y	-2.61%	ROE	10.59%	52W High	27.69 -7.37%	Perf Year	-2.17%
Cash/sh	2.64	P/FCF	14.06	EPS past 3/5Y	-28.69% -13.27%	ROIC	6.52%	52W Low	20.92 22.64%	Perf 3Y	-45.94%
Dividend Est.	1.71 (6.66%)	EV/EBITDA	7.38	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	69.12%	Volatility	2.05% 1.65%	Perf 5Y	-32.09%
Dividend TTM	1.72 (6.71%)	EV/Sales	3.07	EPS Y/Y TTM	128.96%	Oper. Margin	30.99%	ATR (14)	0.49	Perf 10Y	-12.69%
Dividend Ex-Date	Jan 23, 2026	Quick Ratio	0.97	Sales Y/Y TTM	4.44%	Profit Margin	15.60%	RSI (14)	55.28	Recom	2.39
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.28	EPS Q/Q	-20.96%	SMA20	1.64%	Beta	0.43	Target Price	28.51
Payout	120.11%	Debt/Eq	0.66	Sales Q/Q	-5.92%	SMA50	1.33%	Rel Volume	0.92	Prev Close	25.89
Employees	81000	LT Debt/Eq	0.62	Earnings	Feb 03 BMO	SMA200	4.82%	Avg Volume	63.50M	Price	25.65
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	37.53% 0.94%	Trades		Volume	59,470,568	Change	-0.93%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51

Show Previous Ratings

Today 05:54AM	GSK To Acquire RAPT Therapeutics In $2.2 Billion Bet On Food Allergy Breakthrough (Benzinga)
02:54AM	Texas, N. Carolina, Ohio, Pennsylvania where pharma manufacturing investments have surged (Pharma Voice)
Jan-19-26 03:44PM	Down 55%, Should You Buy the Dip on Pfizer? (Motley Fool)
03:23PM	Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All (MarketBeat)
09:31AM	Congresswoman Violates STOCK Act With Over 200 Late Trade Disclosures: Purchases Include Mag7, Healthcare Stocks (Benzinga)
09:01AM	Loading…
09:01AM	What to Expect From Pfizer's Non-Oncology Business in Q4? (Zacks)
Jan-18-26 07:00AM	US drugmakers threaten to withhold products from Europe over prices (Financial Times)
05:04AM	Investing $10,000 in Each of These 5 Ultra-High-Yield Dividend Stocks Could Generate Over $3,700 in Passive Income in 2026 (Motley Fool)
Jan-17-26 09:13AM	The Best Dividend Stocks to Buy in 2026 and Hold Forever -- Including Pfizer (PFE) and United Parcel Service (UPS) (Motley Fool)
Jan-16-26 12:46PM	Pfizer (PFE) CEO Isn't Ready For A Fight With RFK Jr., Says Jim Cramer (Insider Monkey)
06:41AM	Congresswoman Violates STOCK Act With Over 200 Late Trade Disclosures: Purchases Include Mag7, Healthcare Stocks (Benzinga)
02:00AM	Stocks With Juicy Dividends Are Tempting. But How Risky Are They? (Barrons.com)
Jan-15-26 11:40AM	Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30 (Insider Monkey)
08:38AM	Will DefenCath Continue to Aid CorMedix's Top Line in Q4 Earnings? (Zacks)
12:44AM	3SBio Sees More Business Development Deals (Bloomberg)
05:45PM	Loading…
Jan-14-26 05:45PM	Pfizer (PFE) Ascends While Market Falls: Some Facts to Note (Zacks)
08:52AM	Is It Time to Dump Your Shares of Eli Lilly? (Motley Fool)
07:59AM	JPM26: BioNTech gears up for multiproduct oncology status by 2030 (Pharmaceutical Technology)
07:45AM	PFE Market Cap Falls More Than $7B in a Month: How to Play the Stock (Zacks)
04:04AM	BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan (MarketBeat)
Jan-13-26 09:04PM	Amneal Pharmaceuticals Eyes 2026 Growth at JPMorgan, Crexont Sales Seen Doubling in 2025 (MarketBeat)
07:25PM	JPM26: Madrigal seeks early dominance in MASH through strategic acquisitions (Pharmaceutical Technology)
02:50PM	JPM26: Pfizers Metsera deal supercharges its obesity strategy (Pharmaceutical Technology)
01:00PM	Pfizer CEO Says Company Is Pushing for FDA Priority Review Voucher (GuruFocus.com)
12:35PM	ABBV Inks Drug Pricing Deal With Trump, Joins PD-1xVEGF Bandwagon (Zacks)
08:43AM	Will AbbVie's Oncology Segment Support Top-line Growth in Q4 Earnings? (Zacks)
07:54AM	Inside Pfizer's Oncology Performance Ahead of Q4 Results (Zacks)
06:53AM	Health Care Roundup: Market Talk (The Wall Street Journal)
05:24AM	AbbVie Strikes a $100 Billion Deal With Trump. How the Drugmaker Will Dodge Tariffs. (Barrons.com)
Jan-12-26 09:06PM	Adaptive Biotechnologies Touts clonoSEQ MRD Growth, Targets Companywide Profitability in 2026 (MarketBeat)
06:42PM	Loading…
06:42PM	Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra (Reuters)
05:45PM	3 retail trends to watch in 2026, according to NRF 2026 (Yahoo Finance Video)
05:04PM	Health Care Roundup: Market Talk (The Wall Street Journal)
05:00PM	UBS Likes Pfizer's MTSR Obesity Deal but Stays Neutral on PFE (Insider Monkey)
04:21PM	Expect a Busy Year in Obesity Drugs as New Pills Hit the Market (Barrons.com)
04:18PM	JPM Preannouncements: Why Alnylam And Sarepta Lost, But Day One Won (Investor's Business Daily)
01:35PM	Why Tempus AI Stock Jumped on Monday? (GuruFocus.com)
01:08PM	Tempus AI's Pharma Momentum Accelerates (GuruFocus.com)
12:18PM	JPM26: US biotechs Sputnik moment, Pfizers obesity ambitions and Bristol Myers big year (BioPharma Dive)
11:58AM	Pfizer Cancer Combo Drug Shows Strong Tumor Shrinkage in Colorectal Cancer Trial (Benzinga)
11:38AM	'Biotech Super Bowl' Lands With a Thud. Stocks Slide on Lack of Deal News. (Barrons.com)
11:27AM	Why Moderna Stock Is Dropping After Good News (Barrons.com)
11:20AM	MDGL Secures Exclusive Global Right for MASH Treatment From PFE (Zacks)
10:56AM	JPM Preannouncements Take Their Toll As Alnylam Slides, Tempus, Day One Pop (Investor's Business Daily)
06:24AM	AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations (BioPharma Dive)
05:47AM	Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth (Benzinga)
Jan-11-26 11:03AM	This ETF Is Proof That the Healthcare Rebound Is Real (MarketBeat)
Jan-10-26 10:00AM	Pfizers BRAFTOVI Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer (Business Wire)
Jan-09-26 01:30PM	Unusual Options Activity in Pfizer: 2 Strategies Traders Are Jumping On (Barchart)
11:19AM	Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 (Reuters)
09:50AM	Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026 (Motley Fool)
09:16AM	BMY Rallies 17.3% in Six Months: Buy, Sell or Hold the Stock? (Zacks)
07:23AM	J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts (Pharmaceutical Technology)
01:52AM	Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal - Stock Soars Overnight (Benzinga)
Jan-08-26 07:51PM	Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn (Financial Times)
04:30PM	Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026 (Business Wire)
11:59AM	Pfizer Turns To AI Where Drug Risk Is Highest (GuruFocus.com)
11:53AM	Pfizer Partners with Boltz to Use AI in Drug Discovery (GuruFocus.com)
11:46AM	Want Over $2,000 in Dividends Each Year? Invest $12,000 Each Into These 3 Stocks (Motley Fool)
09:35AM	Is LLY's Ventyx Deal Another Attempt at Diversification Beyond GLP-1? (Zacks)
09:13AM	Pfizer, Astellas Report Positive Phase 3 Trial Results for PADCEV Combination in Bladder Cancer Treatment (Insider Monkey)
08:41AM	Fed Governor Wants Huge Rate Cuts This Year: 5 High-Yield Dividend Stocks to Buy Today (24/7 Wall St.)
08:00AM	Biotech Stocks' Dark Winter Is Over. What That Means For Investors. (Investor's Business Daily)
04:10AM	Pfizer's Stock Just Dropped 6%. Can the Pharmaceutical Giant Bounce Back in 2026? (Motley Fool)
Jan-07-26 04:20PM	3 Drug Stocks to Buy at a Discount (Motley Fool)
02:16PM	Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio (Business Wire)
01:35PM	This Could Be Key to Pfizer's Turnaround in 2026 (Motley Fool)
08:33AM	Amgen Buys Dark Blue Therapeutics to Strengthen Oncology Pipeline (Zacks)
Jan-06-26 08:50PM	Warning: This Skyrocketing Stock Has a Hidden Risk (Motley Fool)
11:07AM	iShares Select Dividend Fund Has A Surprisingly High Yield For Retirees (24/7 Wall St.)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:43AM	Pfizer's Quarterly Earnings Preview: What You Need to Know (Barchart)
05:30AM	Big Pharma Has More Going for It Than Obesity Drugs (The Wall Street Journal)
04:11AM	5 of the Safest Ultra-High-Yield Dividend Stocks You Can Confidently Buy for 2026 (Motley Fool)
12:53AM	Motley Fool Money: Stock Market Naughty and Nice List (Motley Fool)
Jan-05-26 10:00PM	Pfizer (PFE) Plans Price Increases on About 80 Medicines Despite Broader Pricing Deals (Insider Monkey)
02:38PM	Flu Season's Here-This Dividend-Payer Controls the Shot Market (MarketBeat)
12:05PM	This Flying-Under-the-Radar Pharma Stock Pays Nearly 7% (While Everyone's Sleeping) (Motley Fool)
10:35AM	These 3 Stocks Trade at Discounts the Market Won't Ignore Forever (MarketBeat)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)
09:20AM	Is It Time to Dump Your Shares of Eli Lilly? (Motley Fool)
08:20AM	Better Dividend Stock: Ford vs. Pfizer (Motley Fool)
Jan-04-26 11:36PM	3 Stocks Under $50 with Questionable Fundamentals (StockStory)
Jan-03-26 05:04AM	How Safe Is Pfizer's Dividend As 2026 Begins? (Motley Fool)
Jan-02-26 05:45PM	Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know (Zacks)
04:50PM	2 Predictions for Pfizer in 2026 (Motley Fool)
10:50AM	Pfizer (PFE) Navigates Patent Losses With Strategic Cost Controls, BMO Capital Reaffirms Outperform Rating (Insider Monkey)
09:51AM	Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China (Zacks)
Jan-01-26 12:57PM	Should You Buy Pfizer While It's Under $30? (Motley Fool)
05:04AM	Investing $122,100 in These 3 High-Yield Dividend Stocks Could Make You $10,000 in Reliable Passive Income in 2026 (Motley Fool)
Dec-31-25 05:50PM	Where Will Pfizer Be in 5 Years? (Motley Fool)
02:08PM	Drugmakers hike US prices on 350 medicines despite pressure from Trump (Reuters Videos)
11:03AM	Pfizer and GSK Lead 2026 U.S. Drug Price Hikes (GuruFocus.com)
10:28AM	Why Wall Street Gave Up on Pfizer-and Why That May Be a Mistake (MarketBeat)
09:34AM	Pfizer, GSK Lead U.S. Drugmakers Planning 2026 Price Hikes on 350 Drugs (GuruFocus.com)
08:03AM	2 Unstoppable Dividend Stocks to Double Up on Right Now (Motley Fool)
07:32AM	Can BMY's Growth Portfolio Drive Top-Line Expansion in 2026? (Zacks)
Dec-30-25 06:02PM	Pfizer (PFE) Braces for Bumpy Years as Growth Pushed Out to 2029 (Insider Monkey)
01:22PM	BMY vs AMGN: Which Biotech Stock Is More Resilient Now? (Zacks)
04:11AM	Want $300 in Super-Safe Dividend Income in 2026? Invest $2,670 Into the Following 3 Ultra-High-Yield Stocks. (Motley Fool)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience